United States · FDA National Drug Code directory

Modafinil

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
23155-604_539210d2-638a-4fd5-a934-d7b5fac982e4
Product NDC
23155-604
Form
TABLET
Composition / generic term
Modafinil
Labeler
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20210218
Source listing expiry
20271231

Source-listed ingredients

  • MODAFINIL — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE, PLASTIC (23155-604-01) · 23155-604-01
  • 30 TABLET in 1 BOTTLE, PLASTIC (23155-604-03) · 23155-604-03
  • 500 TABLET in 1 BOTTLE, PLASTIC (23155-604-05) · 23155-604-05
  • 90 TABLET in 1 BOTTLE, PLASTIC (23155-604-09) · 23155-604-09

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →